Among all supplements marketed to adults over 50, omega-3s have something few others can claim: a broad, consistent, replicated evidence base across multiple body systems — heart, brain, and joints.
This guide covers what's actually proven, the dose that matters, the EPA vs DHA distinction, and how to identify a quality product in a market where quality varies enormously.
Key takeaways
- Only EPA and DHA have proven effects — ALA (from flax) converts at less than 5% and doesn't count
- Cardiovascular: reduces triglycerides 20-30% at 2-4g/day — one of the most robust supplement effects in cardiology
- Brain: DHA makes up 40% of brain fatty acids — maintaining intake after 50 directly correlates with reduced cognitive decline risk
- Joints: meta-analyses show ~15% reduction in stiffness scores — notable for active adults
- Recommended dose: 2-3g of combined EPA+DHA per day (not total fish oil weight)
EPA and DHA: why ALA doesn't count
Omega-3s aren't all equivalent. Three main forms:
- EPA (eicosapentaenoic acid): anti-inflammatory, protects arteries, cardiovascular benefits
- DHA (docosahexaenoic acid): structural component of the brain and retina, critical for cognition
- ALA (alpha-linolenic acid): in flax, chia, hemp seeds. Converts to EPA/DHA at less than 5% in healthy adults — less in adults over 50
Practical consequence: eating flax or taking flaxseed oil isn't enough to cover EPA and DHA needs. The sources that count are fatty fish (salmon, mackerel, sardines, herring) and fish oil or algae supplements (for vegans).
Heart: the most robust effect
The cardiovascular effect of omega-3s is among the best documented in nutrition. At 2-4g EPA+DHA per day, randomized controlled trials show:
- Triglyceride reduction of 20-30% — so significant that the FDA has approved two omega-3-based medications for hypertriglyceridemia
- Blood pressure reduction (modest but consistent across studies)
- Reduced systemic inflammation markers (CRP, IL-6)
For people with cardiovascular history, the European Society of Cardiology has included omega-3s in its recommendations for years. The effect is dose-dependent: dietary doses (fatty fish 2-3 times per week) have a moderate effect, therapeutic doses (2-4g) a significant one.
Brain: DHA as infrastructure
DHA makes up about 40% of the brain's polyunsaturated fatty acids and 60% of the retina. It's not a «supplement» for the brain — it's a structural component. Maintaining it isn't optional.
Age-related cognitive decline is correlated with falling brain DHA levels. Multiple longitudinal cohorts show that high plasma DHA levels are associated with reduced risk of dementia and accelerated cognitive decline. The effect isn't «becoming smarter» — it's maintaining brain structure in a functional state for longer.
Joints: anti-inflammatory effects in practice
EPA is a precursor to anti-inflammatory molecules (resolvins and protectins) involved in resolving joint inflammation. Meta-analyses on rheumatoid arthritis show significant reductions in morning stiffness and joint pain scores. The effect is more modest in mechanical arthropathies (osteoarthritis), but recent data suggests a cartilage health benefit.
For active adults over 50 with chronic joint pain, omega-3s are one of the few supplements with an evidence base strong enough to justify systematic use.
Dose and product selection
The effective dose: 2-3g of combined EPA+DHA per day. Important — that's the weight of EPA+DHA, not the total capsule or oil weight. A 1,000mg fish oil capsule may contain only 300mg of EPA+DHA. Always read the label and look for the actual EPA and DHA content.
Quality criteria:
- Form: triglyceride (TG) or free acid form — better absorbed than ethyl esters
- Freshness: a supplement that «smells fishy» is oxidized. Look for recent manufacture dates and low peroxide values
- Third-party certification: IFOS (International Fish Oil Standards) or equivalent
- Source: small fish (sardines, anchovies, mackerel) have less time to accumulate heavy metals